RESPfRATORY DISZASES AND I~~~~~~H~~~IS~RY Dr. Avery, Dr. Horsfafl and Associates. Biologists, especial>i the geneticists, have long attempted by 17 chemical m6ans to ind*-o,e in higher organizms predictable and specific changes which thereafter could be transmitted in series as hereditary characters. Among 174 croorganksms , the most striking and perhaps the only known example of inheritable and specific alterations in ccl1 structure and function t1lat can be experimentally induced end that are reproducible under ~11 defined and adequately controlled conditions is the transformation of specific ty;?es of Pneumococcus. This phenomenon was first described by Griffith who succeeded in transforming an attenuated and non-tncr+psuI.at,ed (R) variant derived from one specific t:ypc into fully encapsulated and virulent (S) cells of a hetcrologous specific type of i'neumococcus. A typical instince will suffice to illustrate the techniques originally used and serve to indicate the wide variety of transformations that are possible within the bacterial species. For cxamplc, Griffith found that mice in- jected subcutaneously with ;i small amount of a living R culture derived from Pneumococcus Type II together with a large inoculum of heat killed Type III (S) cells frequently succumbed to infection and. that heart's blood of these animals yielded Type III pneumococci in pure culture. The fact that the R strain was avirulent and incapable by itself of causing fatal septicemia, and the additional fact that the heated suspension of Type III cells contained no viable organisms, brought convincing evidence that the R forms growing under these conditions had newly acquired the capsular structure and biological specificity of Type III pneumococci, Griffith wisely refrained from offering an explanation of the phenomenon beyond sug- gesting that the dead bacteria in the inoculum might furnish some specific protein that enables the R forms to manufacture a capsuLar carbohydrate of the same si>eai.fic type as that of the S cells which serve as initial sources of the inducing substance. Althou$ the experiments in mic c v;ere successful, Griffith was unable to repro&xx the phc~;.omcmm wit&xi-l xti~t' passage, and on the basis of negative results concluded that incubation of the bacterial mixture in vitro failed to induce transformation. These original observations -_I_ were later confirmed by a i%nber of people including workers in Dr. Avery's laboratory. Subsequently, it was shown by Dr. Damson in Dr. Avery's labo- ratory that the transformation under certain conditions could be brought about in vitro. Furtiier studies by Dr. UacLeod in Dr. Averyjs laboratory threw light on many of the conditions necessary for the in vitro transfor- -- matlon. For a number of years Dr. Avery and his associates have attempted to obtain in pure form the substance capable of bringing about this type of transformation in pneumococci. He believes that during the past year he Las accomplished this. Vlithout going into the technical details of how the material was obtained in a pure form, it can be stated that a substance, which according to chemical and physical criteria is relatively pure, has been obtained from pneumococci and that it will bring about the transfor- mation SFOkcm of above. This substance is desoxyribonucleic acid (thymus type 1. The fact that the trnnsforming substance in a purified state exhibits little or no immunological reactivity is in striking contrast to its biological function of inducing highly specific changes in living pneumococcal cells. As little as 0.02 pg. representing a final dilution in the reacting system of 1:100,000,000 has sufficed to bring about the transformation of the R variant (R36A) into encapsulated Type III pneumo- cocci. It is impossible as yet to appreciate the full importance of this work; in spl U;: of that there is everjr reason to heliavc that it will have 13 a profound influence on the study of many problems in the biological field and that nucleic acids will assuzze new and broader significance, In 1930 it was first recognized clearly that there exists a com- mon clinical fOrI of pneumoni a which differs from the usual bacterial pneumonias. In the intervening years this illness, nap: termed "primary atypical pneumonia", has been encountered with increasing frequency. In- terest in the condition stems from the facts that at the present time it is seen almost as frequently as is bacterial pneumonia and that the cause or causes of it have not been definitely established. There is reason to believe that this clinical syndrome is not a new disease, It was probably recognized occasionally during the second half of the last century and un- doubtedly was observed not infrequently during each of the first three decades of this century. The recent marked increase in the use of the x-ray in acute respiratory diseases, the establishment of active full-time health units in some schools, colleges and camps, and the ineffectiveness of sulfonamide chemotherapy in the illness seem to have been the most im- portant factors in bringing this syndrome into clear relief. There can be no doubt that this condition, during the past three years, has been increasing in incidence mere rapidly than can be accounted for on the basis merely of increased awareness and recognition of it by physicians. In certain Army camps in the continental United States the in- cidence of the illness has been as high as 1.3 per cent of the total con- mand. It is recognized both by the Army and the Navy as responsible for more man-days lost from duty than almost any other acute infectious disease. The frequency with which the illness occws among civilians cannot now be estimated due to the fact that, with the exception of New York City, the disease is not reportable. 20 ALnost ail investigators v;ho have studied cases of primary atypical pneumonia think that the illness is not the result of bacterial infection. Sc~me workers liavc suggested the possibility that the syndrome is caused by a virus and as a result the term "virus pneumonia" has come into common usage. There is evidence that the syndrome is not a single disease entity. ?S.ach of at least three different infectiotis agents has been shown to be etiologieslly related to certain small groups of CEEXS. These arc the psittacosis group of viruses, Rickettsia diaporica, and a Virus i.nfcctious for t!;e mongoose. Additional infectious agents have been suggested tis possessing il cuusal relationship to other cases although the evidence upon which these suggestions have been based seems insufficient to permit of critical assessment. A comprehensive study of primary atypical pneumonia was begun in the Rockefeller Hospiixl 18 months ago. Tho primary objectives of the study were two-fold: firstly, a detziled study of all the clinical mani- festations of the illness; and secondly, an investigation of the nature of the infectious agents responsible for the syndrome. During this period 112 patients were admitted to the hospital with acute respiratory diseases, Of these, 80 were found to have primary atypical pneumonia. Specimens ob- tained from them constituted the source material for laboratory studies. In addition, specimens were also obtained from 211 patients with the disease in other civilian and military hospitals. All specimens have been stored %t -7O'C. and are constantly available for study. This large library of potentially infectious material has already proven of great value. . AS c? result of the detailed studies of 80 patients with primary atypical pneumonia, it has been possiblo to formulate a fairly accurate 21 clinical pictd~e df the maisdy. It has &isa bztn possible to show that none oi' the usual pnc;unonia-producing bacteria and viruses was the cause of the disease in the patients studied. In addition, it was found that the ser;i of pztients with th ,e disease reacts in a peculiar manner in com- plement-fixution tests. This is an important observation because it in- validates certain conclusions based on the complement-fixation test arrived at by other workers. Finally, Dr. Horsfall and hiis associates have shown in a rather ingenious and indirect way that a virus is responsible for the malady in the patients studied. The workers accomplished t!Cs by inject- ing material from the pa-tients into rabbits and showing that sera taken from such rnbbits possess antibodies against a virus indigenous to white mice and etiologically unrelated to the pneumonia in human beings. Such a test reminds one of the Yieil-Felix reaction in typhus fever. In this test, serum from convalescent typhus patients agglutinates proteus X19, a bacillus that has nothing to do with the causation of typhus fever. Epidemic dysentery among members of the armed forces and civilian population is at present 8 problem of special concern to public health officials and to military authorities. Since the outbreak of the world conflict, clinical bacillary dysentery has been controlled largely through the use of sulfonamide drugs. The problem of procuring an efficacious prophylactic ager.t for the prevention of the disease among closely grouped peoples where the general sanitary conditions cannot be adequately con- trolled, has not been adequately solved. Dr. Goebel and his associates during the past year have attempted to isolate from ccrttain types of Plexner dysentery bacilli, antigens which are relatively nontoxic and which will act as prophylactic vaccine s in animals and human beings. Most of Dr. Coebel's work was conducted on the V strain of Flexner dysentery 22 bacilli b~ecause of the broad serological crossings which this strain ex- hibits wi-th titi.:Lr members of the Fiexner group. He has been able to iso- lzti: in sevcrr;l iwys from thcsi: bacteria a carbohydrate-lipo-protein which when injected into rabbits and human beings leads to the production of zntibodit>s tkzt agg1utir;at.c dysentery ticilli. Further studies of this antigenic substc:nce arc under wy nnd it is hoped that some kind of trial in the field nay bc curried out during the coming year.